Skip to content
Search
SEARCH FOR AN ARTICLE
Posts by PressReach
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
September 30, 2023
![Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium]()
September 30, 2023
